| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.2B | $0.2B | $0.0B | $0.2B | $0.2B | $0.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.1B | $0.0B | $-0.1B | $-0.0B | — | — | — | $0.0B |
| Net Income | $-0.1B | $-0.2B | $0.1B | $-0.0B | $-0.0B | $0.5B | $0.7B | $0.3B |
| EPS (Basic) | $-0.75 | $-1.16 | $0.50 | $-0.04 | $-0.03 | $0.90 | $0.03 | $1.68 |
| EPS (Diluted) | $-0.75 | $-1.16 | $0.49 | $-0.04 | $-0.03 | $0.90 | $0.03 | $1.67 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.0B | $2.1B | $2.2B | $2.4B | $1.8B | $6.8B | $6.2B | $6.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.2B | $0.2B | $0.3B | $0.1B | — | $0.1B |
| Total Liabilities | $1.6B | $1.5B | $1.4B | $1.8B | $1.3B | $4.9B | $4.3B | $4.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.1B | $0.3B | $0.5B | $0.5B | $0.5B | $1.8B | $1.7B | $1.7B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.1B | $0.2B | $0.0B | $0.0B | $0.4B | $0.4B | $0.4B |
| Investing Cash Flow | $0.0B | $-0.3B | $-0.1B | $-0.3B | $-0.1B | $-0.2B | $0.1B | $0.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.0B | $0.1B | $-0.1B | $0.2B | $0.4B | $-0.1B | $-0.6B | $-0.4B |